Need professional-grade analysis? Visit stockanalysis.com
$47.86M
N/A
N/A
N/A
Inoviq Ltd (IIQ) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD0.34, up 1.49% from the previous close.
Over the past year, IIQ has traded between a low of AUD0.32 and a high of AUD0.56. The stock has lost 10.5% over this period. It is currently 39.8% below its 52-week high.
Inoviq Ltd has a market capitalization of $47.86M.
INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.
Side-by-side comparison against top Healthcare peers.